HEADER LIGASE 04-OCT-04 1WQW TITLE CRYSTAL STRUCTURE OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS HORIKOSHII TITLE 2 OT3 IN COMPLEX WITH BIOTINYL-5-AMP COMPND MOL_ID: 1; COMPND 2 MOLECULE: BIOTIN--[ACETYL-COA-CARBOXYLASE] LIGASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 6.3.4.15; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PYROCOCCUS HORIKOSHII; SOURCE 3 ORGANISM_TAXID: 70601; SOURCE 4 STRAIN: OT3; SOURCE 5 GENE: BIRA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: (DE3)RIL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET 11A KEYWDS BIOTIN PROTEIN LIGASE, DIMER, STRUCTURAL GENOMICS, RIKEN STRUCTURAL KEYWDS 2 GENOMICS/PROTEOMICS INITIATIVE, RSGI, LIGASE EXPDTA X-RAY DIFFRACTION AUTHOR B.BAGAUTDINOV,N.KUNISHIMA,RIKEN STRUCTURAL GENOMICS/PROTEOMICS AUTHOR 2 INITIATIVE (RSGI) REVDAT 4 25-OCT-23 1WQW 1 REMARK REVDAT 3 13-JUL-11 1WQW 1 VERSN REVDAT 2 24-FEB-09 1WQW 1 VERSN REVDAT 1 04-OCT-05 1WQW 0 JRNL AUTH B.BAGAUTDINOV,C.KUROISHI,M.SUGAHARA,N.KUNISHIMA JRNL TITL CRYSTAL STRUCTURES OF BIOTIN PROTEIN LIGASE FROM PYROCOCCUS JRNL TITL 2 HORIKOSHII OT3 AND ITS COMPLEXES: STRUCTURAL BASIS OF BIOTIN JRNL TITL 3 ACTIVATION JRNL REF J.MOL.BIOL. V. 353 322 2005 JRNL REFN ISSN 0022-2836 JRNL PMID 16169557 JRNL DOI 10.1016/J.JMB.2005.08.032 REMARK 2 REMARK 2 RESOLUTION. 1.45 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.45 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.49 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 90.9 REMARK 3 NUMBER OF REFLECTIONS : 71511 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.240 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 3641 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3674 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 76 REMARK 3 SOLVENT ATOMS : 1031 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 18.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.14000 REMARK 3 B22 (A**2) : -4.70000 REMARK 3 B33 (A**2) : 4.56000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 3.26000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.18 REMARK 3 ESD FROM SIGMAA (A) : 0.16 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.20 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.16 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.80 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.860 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ANISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1WQW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 07-OCT-04. REMARK 100 THE DEPOSITION ID IS D_1000023893. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-JUN-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL26B1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS V REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 71511 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.450 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.3 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.05200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.45 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.50 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.3 REMARK 200 DATA REDUNDANCY IN SHELL : 3.20 REMARK 200 R MERGE FOR SHELL (I) : 0.37500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.570 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: CNS 1.1 REMARK 200 STARTING MODEL: PDB ENTRY 1WQ7 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.14 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG20K, ACETATE, NAOH, PH 5.2, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 41.41600 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A DIMER REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4080 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20350 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -18.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 8 -59.24 -124.66 REMARK 500 ARG A 48 -76.72 -7.53 REMARK 500 LEU A 49 -85.85 -94.96 REMARK 500 ASN A 50 13.98 -146.87 REMARK 500 PRO A 76 -8.84 -59.77 REMARK 500 VAL A 132 -77.81 -108.50 REMARK 500 ASP A 206 -176.04 179.44 REMARK 500 ILE B 8 -59.19 -120.91 REMARK 500 LEU B 49 79.42 -160.31 REMARK 500 SER B 67 65.02 -151.61 REMARK 500 VAL B 132 -77.58 -113.31 REMARK 500 ASP B 206 -173.89 -176.87 REMARK 500 ASP B 229 36.30 -89.04 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BT5 A 1301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BT5 B 1302 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1WNL RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH ADP REMARK 900 RELATED ID: 1WPY RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH BIOTIN REMARK 900 RELATED ID: 1WQ7 RELATED DB: PDB REMARK 900 THE SAME PROTEIN REMARK 900 RELATED ID: PHO001000147.8 RELATED DB: TARGETDB DBREF 1WQW A 1 235 UNP O57883 O57883_PYRHO 1 235 DBREF 1WQW B 1 235 UNP O57883 O57883_PYRHO 1 235 SEQRES 1 A 235 MET LEU GLY LEU LYS THR SER ILE ILE GLY ARG ARG VAL SEQRES 2 A 235 ILE TYR PHE GLN GLU ILE THR SER THR ASN GLU PHE ALA SEQRES 3 A 235 LYS THR SER TYR LEU GLU GLU GLY THR VAL ILE VAL ALA SEQRES 4 A 235 ASP LYS GLN THR MET GLY HIS GLY ARG LEU ASN ARG LYS SEQRES 5 A 235 TRP GLU SER PRO GLU GLY GLY LEU TRP LEU SER ILE VAL SEQRES 6 A 235 LEU SER PRO LYS VAL PRO GLN LYS ASP LEU PRO LYS ILE SEQRES 7 A 235 VAL PHE LEU GLY ALA VAL GLY VAL VAL GLU THR LEU LYS SEQRES 8 A 235 GLU PHE SER ILE ASP GLY ARG ILE LYS TRP PRO ASN ASP SEQRES 9 A 235 VAL LEU VAL ASN TYR LYS LYS ILE ALA GLY VAL LEU VAL SEQRES 10 A 235 GLU GLY LYS GLY ASP LYS ILE VAL LEU GLY ILE GLY LEU SEQRES 11 A 235 ASN VAL ASN ASN LYS VAL PRO ASN GLY ALA THR SER MET SEQRES 12 A 235 LYS LEU GLU LEU GLY SER GLU VAL PRO LEU LEU SER VAL SEQRES 13 A 235 PHE ARG SER LEU ILE THR ASN LEU ASP ARG LEU TYR LEU SEQRES 14 A 235 ASN PHE LEU LYS ASN PRO MET ASP ILE LEU ASN LEU VAL SEQRES 15 A 235 ARG ASP ASN MET ILE LEU GLY VAL ARG VAL LYS ILE LEU SEQRES 16 A 235 GLY ASP GLY SER PHE GLU GLY ILE ALA GLU ASP ILE ASP SEQRES 17 A 235 ASP PHE GLY ARG LEU ILE ILE ARG LEU ASP SER GLY GLU SEQRES 18 A 235 VAL LYS LYS VAL ILE TYR GLY ASP VAL SER LEU ARG PHE SEQRES 19 A 235 LEU SEQRES 1 B 235 MET LEU GLY LEU LYS THR SER ILE ILE GLY ARG ARG VAL SEQRES 2 B 235 ILE TYR PHE GLN GLU ILE THR SER THR ASN GLU PHE ALA SEQRES 3 B 235 LYS THR SER TYR LEU GLU GLU GLY THR VAL ILE VAL ALA SEQRES 4 B 235 ASP LYS GLN THR MET GLY HIS GLY ARG LEU ASN ARG LYS SEQRES 5 B 235 TRP GLU SER PRO GLU GLY GLY LEU TRP LEU SER ILE VAL SEQRES 6 B 235 LEU SER PRO LYS VAL PRO GLN LYS ASP LEU PRO LYS ILE SEQRES 7 B 235 VAL PHE LEU GLY ALA VAL GLY VAL VAL GLU THR LEU LYS SEQRES 8 B 235 GLU PHE SER ILE ASP GLY ARG ILE LYS TRP PRO ASN ASP SEQRES 9 B 235 VAL LEU VAL ASN TYR LYS LYS ILE ALA GLY VAL LEU VAL SEQRES 10 B 235 GLU GLY LYS GLY ASP LYS ILE VAL LEU GLY ILE GLY LEU SEQRES 11 B 235 ASN VAL ASN ASN LYS VAL PRO ASN GLY ALA THR SER MET SEQRES 12 B 235 LYS LEU GLU LEU GLY SER GLU VAL PRO LEU LEU SER VAL SEQRES 13 B 235 PHE ARG SER LEU ILE THR ASN LEU ASP ARG LEU TYR LEU SEQRES 14 B 235 ASN PHE LEU LYS ASN PRO MET ASP ILE LEU ASN LEU VAL SEQRES 15 B 235 ARG ASP ASN MET ILE LEU GLY VAL ARG VAL LYS ILE LEU SEQRES 16 B 235 GLY ASP GLY SER PHE GLU GLY ILE ALA GLU ASP ILE ASP SEQRES 17 B 235 ASP PHE GLY ARG LEU ILE ILE ARG LEU ASP SER GLY GLU SEQRES 18 B 235 VAL LYS LYS VAL ILE TYR GLY ASP VAL SER LEU ARG PHE SEQRES 19 B 235 LEU HET BT5 A1301 38 HET BT5 B1302 38 HETNAM BT5 BIOTINYL-5-AMP FORMUL 3 BT5 2(C20 H28 N7 O9 P S) FORMUL 5 HOH *1031(H2 O) HELIX 1 1 SER A 21 SER A 29 1 9 HELIX 2 2 ASP A 74 PRO A 76 5 3 HELIX 3 3 LYS A 77 PHE A 93 1 17 HELIX 4 4 SER A 142 GLY A 148 1 7 HELIX 5 5 PRO A 152 ASN A 174 1 23 HELIX 6 6 MET A 176 MET A 186 1 11 HELIX 7 7 SER B 21 SER B 29 1 9 HELIX 8 8 PRO B 71 PRO B 76 5 6 HELIX 9 9 LYS B 77 PHE B 93 1 17 HELIX 10 10 SER B 142 GLY B 148 1 7 HELIX 11 11 PRO B 152 ASN B 174 1 23 HELIX 12 12 MET B 176 ASP B 184 1 9 SHEET 1 A14 ARG A 98 LYS A 100 0 SHEET 2 A14 ASP A 104 VAL A 107 -1 O LEU A 106 N ARG A 98 SHEET 3 A14 LYS A 110 LYS A 120 -1 O ALA A 113 N VAL A 105 SHEET 4 A14 LYS A 123 LEU A 130 -1 O VAL A 125 N GLU A 118 SHEET 5 A14 LEU A 60 LEU A 66 -1 N LEU A 66 O ILE A 124 SHEET 6 A14 VAL A 36 GLN A 42 -1 N ILE A 37 O SER A 63 SHEET 7 A14 ARG A 12 ILE A 19 1 N ILE A 14 O VAL A 36 SHEET 8 A14 ARG B 12 ILE B 19 -1 O TYR B 15 N VAL A 13 SHEET 9 A14 VAL B 36 GLN B 42 1 O VAL B 36 N ILE B 14 SHEET 10 A14 LEU B 60 LEU B 66 -1 O SER B 63 N ILE B 37 SHEET 11 A14 ILE B 124 LEU B 130 -1 O ILE B 128 N LEU B 62 SHEET 12 A14 LYS B 110 GLY B 119 -1 N GLU B 118 O VAL B 125 SHEET 13 A14 ASP B 104 VAL B 107 -1 N VAL B 105 O ILE B 112 SHEET 14 A14 ARG B 98 LYS B 100 -1 N ARG B 98 O LEU B 106 SHEET 1 B 5 VAL A 222 VAL A 225 0 SHEET 2 B 5 LEU A 213 ARG A 216 -1 N LEU A 213 O VAL A 225 SHEET 3 B 5 SER A 199 ILE A 207 -1 N ASP A 206 O ILE A 214 SHEET 4 B 5 ARG A 191 LEU A 195 -1 N ILE A 194 O PHE A 200 SHEET 5 B 5 SER A 231 PHE A 234 -1 O SER A 231 N LEU A 195 SHEET 1 C 5 VAL B 222 VAL B 225 0 SHEET 2 C 5 LEU B 213 ARG B 216 -1 N LEU B 213 O VAL B 225 SHEET 3 C 5 PHE B 200 ILE B 207 -1 N ASP B 206 O ILE B 214 SHEET 4 C 5 VAL B 190 ILE B 194 -1 N VAL B 192 O GLY B 202 SHEET 5 C 5 LEU B 232 PHE B 234 -1 O ARG B 233 N LYS B 193 CISPEP 1 TRP A 101 PRO A 102 0 -0.72 CISPEP 2 TRP B 101 PRO B 102 0 0.16 SITE 1 AC1 29 SER A 21 THR A 22 ASN A 23 GLN A 42 SITE 2 AC1 29 GLY A 45 HIS A 46 GLY A 47 ARG A 48 SITE 3 AC1 29 ARG A 51 LYS A 52 TRP A 53 GLU A 54 SITE 4 AC1 29 LEU A 62 ASN A 103 ASP A 104 LYS A 111 SITE 5 AC1 29 GLY A 114 ILE A 128 GLY A 129 ASN A 131 SITE 6 AC1 29 PRO A 137 ALA A 140 HOH A1448 HOH A1580 SITE 7 AC1 29 HOH A1582 HOH A1689 HOH A1690 HOH A1697 SITE 8 AC1 29 HOH A1716 SITE 1 AC2 24 SER B 21 THR B 22 ASN B 23 GLN B 42 SITE 2 AC2 24 GLY B 45 HIS B 46 GLY B 47 ARG B 48 SITE 3 AC2 24 ARG B 51 LYS B 52 TRP B 53 GLU B 54 SITE 4 AC2 24 LEU B 62 ASN B 103 ASP B 104 LYS B 111 SITE 5 AC2 24 GLY B 114 VAL B 115 ILE B 128 GLY B 129 SITE 6 AC2 24 ASN B 131 ALA B 140 HOH B1510 HOH B1617 CRYST1 38.348 82.832 72.785 90.00 102.15 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.026077 0.000000 0.005614 0.00000 SCALE2 0.000000 0.012073 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014054 0.00000